Although antioxidants do not alleviate a G6PD deficient hematologic phenotype, are they effective for treatment of chronic diseases associated with G6PD deficiency
A GLP-1 blocker acts by inhibiting the GLP-1 receptor, which modulates the downstream inflammatory pathways linked to: cytokine production immune system activation oxidative stress inflammatory signaling in tissues such as the liver, fat cells, and gut In low doses, blocking GLP-1 receptors appears to influence the immune system without significantly interfering with glucose control which is why this approach is being studied specifically for inflammation rather than metabolic disease
Migone T-S, Subramanian GM, Zhong J, Healey LM, Corey A, Devalaraja M, et al
4.4 Zinc Zinc can protect melanocytes through its anti-apoptotic and antioxidant effects
Hormone Replacement and Peptide Therapy Reclaim Balance